BDH2 and nasopharyngeal carcinoma: A low level of BDH2 (3-hydroxybutyrate dehydrogenase 2) amplifies NPC cell malignant behaviours by promoting intracellular iron overload, indicating that reduced intracellular iron might be favourable for NPC treatment (103).